CytoTerra is a startup based in the United States.
CytoTerra develops next-generation cancer diagnostics using a single comprehensive assay that eliminates the need for multiple cytogenetic tests, providing genome-wide cytogenetic analysis to deliver actionable insights for clinicians and patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.